Powtech 2014 coincides with the third anniversary of the launch of the Mastersizer 3000 laser diffraction particle size analyzer from Malvern Instruments. In celebration, Malvern will use this occasion to introduce visitors to the latest Mastersizer accessories.
Researchers at The School of Freshwater Science, University of Wisconsin-Milwaukee, USA, are using NanoSight Nanoparticle Tracking Analysis (NTA) from Malvern Instruments to investigate the effects of nanoparticle contaminants on freshwater organisms.
The new Zetasizer Helix from Malvern Instruments is a powerful tool for early stage biopharmaceutical development that enables the detailed study of mechanisms of protein aggregation.
The growth of the auto injector industry has been driven largely in part by the need to improve patient compliance and quality of life (QOL). From human factors and usability studies to new injection technologies and breakthrough manufacturing processes, the ultimate goal of an auto injector device is to enhance the injection experience while ensuring the desired drug is delivered safely and effectively.
Following the acquisition of GXP Limited where the purchase price was paid in part in newly issued shares, the number of shares and votes in the company has increased by 1,208,814 and the share capital has increased by SEK 120, 881.40.
Woodley is pleased to announce the appointment of Sarah Dopson as Purchasing Manager in our Clinical Trials Division. Sarah has many years of experience in the global medical equipment supply chain and her appointment will reinforce our relationships with our network of suppliers, improving on standard lead times and achieving the best price.
Malvern Instruments has launched NTA 3.0, a new version of the software that drives its NanoSight Nanoparticle Tracking Analysis (NTA) systems.
We are proud to announce that some weeks ago at Cafosa we achieved the Workplace Conditions Assesment (WCA) by Intertek.
Formpipe has announced its interim report, from January to June 2014.
Formpipe has acquired the UK company GXP Limited ('GXPi'), an established provider of compliance solutions for the life science industry. The acquisition strengthens Formpipe's platform for growth in the life science industry and the acquisition has positive effects such as stronger international sales and marketing organization, an expanded product offering and an attractive customer base, both in Europe and the United States.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.